Adding Chromadex (CDXC) to the Tailwinds Select Portfolio

This morning we have added Chromadex to the Tailwinds Select Portfolio at a price of $3.91. Chromadex holds the worldwide rights to Niagen, a member of the vitamin B-3 family that helps promote healthier living and longer lives. CDXC will benefit from any increase in the sales of Niagen related products and is also working on rolling out their own branded products.

With a recent investment from Hong Kong billionaire Li Ka-Shing, Chromadex has a strong partner with worldwide distribution platforms. Sales of Niagen products look ready to boom and Chromadex will be the major beneficiary of this trend.

LEAVE A REPLY